deaths (OS)

mNSCLC - L1 - all population metastatic/advanced NSCLC (mNSCLC) - 1st line (L1) mNSCLC - L1 - all population

versus Standard of Care (SoC)
cemiplimab vs. Standard of Care (SoC) 1 0.68 [0.53; 0.87], 1 RCT, I2=0% conclusive
unassessable degree of certainty